The regulation of homeopathic drugs as complementary and alternative medicine products: The role of the homeopathic pharmacopoeia of the United States

Please use this identifier to cite or link to this item: http://aohindia.in/xmlui/handle/123456789/1982

Full metadata record

DC Field	Value	Language
dc.contributor.author	Borneman, JP	-
dc.date.accessioned	2019-04-12T11:14:18Z	-
dc.date.available	2019-04-12T11:14:18Z	-
dc.date.issued	2007	-
dc.identifier.citation	American Journal of Homeopathic Medicine, Vol.100(4)	en_US
dc.identifier.uri	http://aohindia.in:8080/xmlui/handle/123456789/1982	-
dc.description.abstract	FDA classifications and regulation of allopathic drugs homeopathic drugs and dietary supplements are contrasted. The role of the HPCUS in regulation of homeopathic medicines is described and the HPCUS durg approval process is detailed.	en_US
dc.language.iso	en	en_US
dc.subject	Allopathic drug	en_US
dc.subject	FDA classification and regulation	en_US
dc.title	The regulation of homeopathic drugs as complementary and alternative medicine products: The role of the homeopathic pharmacopoeia of the United States	en_US
dc.type	Article	en_US
Appears in Collections:	Digitised Articles

Files in This Item:

File	Description	Size	Format
American Journal Of Homeopathic Medicine vol 100,Oct 2007,pp 258-264.pdf Restricted Access		1.28 MB	Adobe PDF	View/Open Request a copy